Search Tag: naltrexone-bupropion

Cardiology Management

Cardiovascular-safety-of-obesity-drugs

2016 08 Mar

According to a study published in JAMA , the cardiovascular safety of obesity drug combination naltrexone-bupropion is uncertain especially in light of the unanticipated early termination of a clinical trial to determine its safety.  To date, drugs that have been used to treat obesity have only provided mixed results and modest weight loss. No...Read more